The prediction of malignant cerebral infarction by molecular brain barrier disruption markers

被引:146
作者
Serena, J
Blanco, M
Castellanos, M
Silva, Y
Vivancos, J
Moro, MA
Leira, R
Lizasoain, I
Castillo, J
Dávalos, A
机构
[1] Hosp Univ Doctor Josep Trueta, Stroke Unit, Dept Neurol, Girona 17007, Spain
[2] Hosp Clin Univ, Dept Neurol, Santiago De Compostela, Spain
[3] Hosp Univ Princesa, Dept Neurol, Madrid, Spain
[4] Univ Complutense Madrid, Fac Med, Dept Pharmacol, Madrid, Spain
[5] Hosp Germans Trias & Pujol, Dept Neurosci, Badalona, Spain
关键词
brain edema; craniectomy; stroke;
D O I
10.1161/01.STR.0000177870.14967.94
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - Space-occupying brain edema is a life-threatening complication in patients with large hemispheric stroke. The aim of the study was to determine whether molecular markers of endothelial damage may help to predict secondary brain edema and, secondly, to identify patients who could benefit from aggressive therapies such as decompressive hemicraniectomy or hypothermia. Methods - We studied 40 consecutive patients with malignant middle cerebral artery (MCA) infarction and 35 controls with massive MCA infarctions <70 years of age and matched by stroke severity on admission. Cranial computed tomography (CT) was performed at entry and repeated between days 4 and 7, or earlier if there was neurological worsening. Malignant MCA (m-MCA) infarction was diagnosed when follow-up CT detected a more than two-thirds space-occupying MCA infarction with midline shift, compression of the basal cisterns, and neurological deterioration. Plasma concentrations of glutamate, glycine, gamma-aminobutyric acid, interleukin-6 (IL-6), IL-10, tumor necrosis factor-alpha, matrix metalloproteinase-9 (MMP-9), and cellular-fibronectin (c-Fn) were determined in blood samples obtained at admission. Results - Mean time from stroke onset to blood sampling was 6.3 +/- 4.8 in m-MCA and 7.7 +/- 6.0 hours in the control group (P=0.63). Baseline characteristics were comparable in both groups. c-Fn and MMP-9 levels were significantly higher in patients with m-MCA than in controls (all P<0.001). c-Fn >16.6 mu g/mL had the highest sensitivity (90%), specificity (100%), and negative and positive predictive values (89% and 100%, respectively) for the prediction of m-MCA infarction. Conclusions - A plasma c-Fn concentration >16.6 mu g/mL at admission is associated with the development of m-MCA infarction with high sensitivity and specificity, suggesting that c-Fn might be useful in therapeutic decision making.
引用
收藏
页码:1921 / 1926
页数:6
相关论文
共 28 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[3]   Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care [J].
Berrouschot, J ;
Sterker, M ;
Bettin, S ;
Koster, J ;
Schneider, D .
INTENSIVE CARE MEDICINE, 1998, 24 (06) :620-623
[4]   Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke [J].
Castellanos, M ;
Leira, R ;
Serena, J ;
Blanco, M ;
Pedraza, S ;
Castillo, J ;
Dávalos, A .
STROKE, 2004, 35 (07) :1671-1676
[5]   Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke [J].
Castellanos, M ;
Leira, R ;
Serena, J ;
Pumar, JM ;
Lizasoain, I ;
Castillo, J ;
Dávalos, A .
STROKE, 2003, 34 (01) :40-45
[6]   Progression of ischaemic stroke and excitotoxic aminoacids [J].
Castillo, J ;
Davalos, A ;
Noya, M .
LANCET, 1997, 349 (9045) :79-83
[7]   Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia [J].
Clark, AW ;
Krekoski, CA ;
Bou, SS ;
Chapman, KR ;
Edwards, DR .
NEUROSCIENCE LETTERS, 1997, 238 (1-2) :53-56
[8]   THE CANADIAN NEUROLOGICAL SCALE - VALIDATION AND RELIABILITY ASSESSMENT [J].
COTE, R ;
BATTISTA, RN ;
WOLFSON, C ;
BOUCHER, J ;
ADAM, J ;
HACHINSKI, V .
NEUROLOGY, 1989, 39 (05) :638-643
[9]   Prediction of malignant course in MCA infarction by PET and microdialysis [J].
Dohmen, C ;
Bosche, B ;
Graf, R ;
Staub, F ;
Kracht, L ;
Sobesky, J ;
Neveling, M ;
Brinker, G ;
Heiss, WD .
STROKE, 2003, 34 (09) :2152-2158
[10]   'Malignant' middle cerebral artery territory infarction - Clinical course and prognostic signs [J].
Hacke, W ;
Schwab, S ;
Horn, M ;
Spranger, M ;
DeGeorgia, M ;
vonKummer, R .
ARCHIVES OF NEUROLOGY, 1996, 53 (04) :309-315